Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study by Nilsson, Sten, Prof, Franzén, Lars, MD, Parker, Christopher, Dr, Tyrrell, Christopher, FRCR, Blom, René, MD, Tennvall, Jan, Prof, Lennernäs, Bo, MD, Petersson, Ulf, MD, Johannessen, Dag C, MD, Sokal, Michael, FRCR, Pigott, Katharine, FRCR, Yachnin, Jeffrey, MD, Garkavij, Michael, MD, Strang, Peter, Prof, Harmenberg, Johan, MD, Bolstad, Bjørg, MSc, Bruland, Øyvind S, Prof

Get full text

4054 POSTER Placebo-controlled, randomized, phase II study of radium-223 in metastatic hormone refractory prostate cancer (HRPC) by Nilsson, S, Franzén, L, Tyrrell, C, Blom, R, Tennvall, J, Lennernäs, B, Johannessen, D.C, Sokal, M, Parker, C, Bruland, O.S

Get full text

130 Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients wit... by Parker, C, Heinrich, D, Helle, S.I, O'Sullivan, J.M, Fossä, S, Chodacki, A, Demkow, T, Logue, J, Seke, M, Widmark, A, Johannessen, D.C, Nilsson, S, Hoskin, P, Bottomley, D, Solberg, A, James, N.D, Syndikus, I, Wedel, S.A, Kliment, J, Cross, A, O'Bryan-Tear, C.G, Garcia-Vargas, J, Sartor, O

Get full text

Treatment with formestane alone and in combination with aminoglutethimide in heavily pretreated breast cancer patients: Clinical and endocrine effects by Geisler, J., Johannessen, D.C., Anker, G., Lønning, P.E.

Get full text

Plasma estrogen suppression with aromatase inhibitors evaluated by a novel, sensitive assay for estrone sulphate by Lønning, P.E., Geisler, J., Johannessen, D.C., Ekse, D.

Get full text

Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients by Lønning, P.E., Johannessen, D.C., Lien, E.A., Ekse, D., Fotsis, T., Adlercreutz, H.

Get full text